NYSE - Delayed Quote • USD
Elevance Health, Inc. (ELV)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 7:48 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 19 | 19 | 20 | 20 |
| Avg. Estimate | 10.01 | 9.82 | 37.28 | 41.64 |
| Low Estimate | 9.82 | 9.21 | 37.2 | 40.11 |
| High Estimate | 10.28 | 10.51 | 37.38 | 42.3 |
| Year Ago EPS | 9.04 | 8.99 | 33.14 | 37.28 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 17 | 17 |
| Avg. Estimate | 42.97B | 42.93B | 171.9B | 182.92B |
| Low Estimate | 42.4B | 42.45B | 170.44B | 178.56B |
| High Estimate | 43.53B | 43.62B | 173.93B | 187.68B |
| Year Ago Sales | -- | 42.62B | 170.21B | 171.9B |
| Sales Growth (year/est) | -- | 0.70% | 1.00% | 6.40% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 8.8 | 8.44 | 5.64 | 10.53 |
| EPS Actual | 9.04 | 8.99 | 5.62 | 10.64 |
| Difference | 0.24 | 0.55 | -0.02 | 0.11 |
| Surprise % | 2.70% | 6.50% | -0.40% | 1.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 10.01 | 9.82 | 37.28 | 41.64 |
| 7 Days Ago | 10.02 | 9.83 | 37.27 | 41.65 |
| 30 Days Ago | 10.01 | 9.83 | 37.28 | 41.62 |
| 60 Days Ago | 10.15 | 9.83 | 37.14 | 41.54 |
| 90 Days Ago | 10.13 | 9.85 | 37.13 | 41.54 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ELV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 10.70% | -- | -- | 9.10% |
| Next Qtr. | 9.20% | -- | -- | 11.50% |
| Current Year | 12.50% | -- | -- | 5.70% |
| Next Year | 11.70% | -- | -- | 12.60% |
| Next 5 Years (per annum) | 12.10% | -- | -- | 11.34% |
| Past 5 Years (per annum) | 12.97% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | B of A Securities: Buy to Buy | 6/4/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 5/30/2024 |
| Initiated | Baird: Outperform | 5/30/2024 |
| Maintains | Mizuho: Buy to Buy | 4/24/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 4/19/2024 |
| Maintains | UBS: Buy to Buy | 4/19/2024 |
Related Tickers
CI The Cigna Group
338.10
+0.06%
HUM Humana Inc.
351.80
-1.02%
CNC Centene Corporation
69.81
-0.89%
MOH Molina Healthcare, Inc.
309.56
-1.23%
UNH UnitedHealth Group Incorporated
490.69
-2.24%
CVS CVS Health Corporation
61.78
+1.38%
OSCR Oscar Health, Inc.
19.32
-0.92%
ALHC Alignment Healthcare, Inc.
8.34
-0.60%
CLOV Clover Health Investments, Corp.
1.1000
0.00%
NEUE NeueHealth, Inc.
5.55
-4.31%